Skip to Content

CYP 516 (Uritact DS 0.06 mg-81.6 mg-10.8 mg-36.2 mg)

Generic Name: hyoscyamine/methenamine/methylene blue/phenyl salicylate

Pill imprint CYP 516 has been identified as Uritact DS 0.06 mg-81.6 mg-10.8 mg-36.2 mg.

Uritact DS is used in the treatment of urinary tract infection and belongs to the drug class urinary antispasmodics. Risk cannot be ruled out during pregnancy. Uritact DS 0.06 mg-81.6 mg-10.8 mg-36.2 mg is not a controlled substance under the Controlled Substance Act (CSA).

Uritact DS
Generic Name:
hyoscyamine/methenamine/methylene blue/phenyl salicylate
Imprint:
CYP 516
Strength:
0.06 mg-81.6 mg-10.8 mg-36.2 mg
Color:
Blue
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Urinary antispasmodics
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Manufacturer:
Cypress Pharmaceutical Inc

More info Print Imprint Search

More about Uritact DS (hyoscyamine / methenamine / methylene blue / phenyl salicylate)

Consumer resources

Related treatment guides

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide